Showing results (231-240 of 522) with videos related to

Sort By:
Pageof 53
The Journal of Infectious Diseases|July 29, 2000
Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 diseaseS Emery, W B Capra, D A Cooper, et al.
JACC. Cardiovascular Imaging|December 11, 2020
Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expert Consensus StatementDermot Phelan, Jonathan H Kim, Michael D Elliott, et al.
HIV Medicine|September 4, 2010
Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)S L Pett, C Carey, E Lin, et al.
Progress in Cardiovascular Diseases|April 29, 2023
Exercise and cardiovascular health: A state-of-the-art reviewAmeesh Isath, Klaudia J Koziol, Matthew W Martinez, et al.
ACS Omega|February 10, 2025
Fragment Screening Reveals Novel Scaffolds against Sirtuin-2-Related Protein 1 from Trypanosoma bruceiRenan A Gomes, Marcelo D Polêto, Hugo Verli, et al.
Human Vaccines|March 15, 2008
Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapyS Emery, A D Kelleher, C Workman, et al.
Microbial Pathogenesis|March 15, 2020
Structure-activity relationships and mechanism of action of tetragomycin derivatives as inhibitors of Staphylococcus aureus staphyloxanthin biosynthesisL M B C Ribeiro, F Fumagalli, R B Mello, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
AIDS (London, England)|January 11, 2000
A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in ThailandK Ruxrungtham, S Suwanagool, J A Tavel, et al.
International Immunopharmacology|January 22, 2013
3-Phenylcoumarin derivatives selectively modulate different steps of reactive oxygen species production by immune complex-stimulated human neutrophilsMicássio F Andrade, Luciana M Kabeya, Ana Elisa C S Azzolini, et al.
Pageof 53